Navigation Links
The PLSG Invests $115,000 in Innovention Technologies, LLC
Date:10/24/2007

PITTSBURGH, Oct. 24 /PRNewswire/ -- The Pittsburgh Life Sciences Greenhouse (PLSG), the private/public partnership putting the region's life sciences industry on a fast track for growth, announced that the PLSG has invested $115,000 in Innovention Technologies, LLC, a developmental-stage medical device company, whose goal is to develop and commercialize a highly-maneuverable surgical probe that will alleviate the existing limitations of endoscopic devices used in minimally invasive surgery (MIS).

Innovention Technologies is a spin-out from Carnegie Mellon University and it is led by an interdisciplinary team of experts in robotics, robotic surgery and minimally-invasive cardiac surgery (MICS).

Innovention Technologies is developing advanced robotic technologies for use in a wide range of applications, including: medical, industrial, military and law enforcement. The company's highly articulated robotic probes have unlimited degrees of freedom, are teleoperated, and are able to steer a self-supported, non-linear path. Innoventions' first product is a highly-articulated robotic probe (HARP) with feeder (the "HARP Product"). The HARP Product is highly maneuverable and once entered through a natural orifice or small incision, is designed to steer around organs to reach anatomical targets not normally accessible by conventional endoscopic tools. The HARP mechanical features include its ability to alternate between being rigid and flexible, and "remember" its previous configurations. This allows the HARP to reach very small cavities within the body and remain in a desired shape and orientation while the doctor performs surgery without having to hold the device anymore.

"The PLSG is excited to support Innoventions' continued commercialization efforts. Innoventions' core technology promises to combine advanced, yet simple methodologies in robotic surgery to more effectively deliver intended surgical benefits for increased patient care," said John W. Manzetti, PLSG's President and CEO. Mr. Manzetti continued, "The experienced management team has combined MIS and an emerging robotics technology to strategically and competitively position Innoventions in a large medical device market."

About the Pittsburgh Life Sciences Greenhouse (PLSG)

The PLSG invests in and supports the growth of biosciences companies in southwestern Pennsylvania. The PLSG has investment and business growth programs to increase the linkage between research, technology and commercialization; nurture and develop entrepreneurial biosciences enterprises; grow the region's talent pool in the life sciences; and help biosciences firms locate, expand or start-up in the Greater Pittsburgh region. http://www.plsg.com

About Innovention Technologies, LLC

Innovention Technologies LLC is developing advanced robotic technologies for use in a wide range of applications, including: medical, industrial, military and law enforcement. The Company's highly articulated robotic probes have unlimited degrees of freedom, are teleoperated, and are able to steer a self-supported, non-linear path. Within the medical field, the Company plans to serve a number of different specialist areas, including: minimally-invasive cardiac surgery, electrophysiology, laparoscopy, colonoscopy and arthroscopy. http://www.innoventllc.com


'/>"/>
SOURCE Pittsburgh Life Sciences Greenhouse
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Milwaukee angel network invests in St. Louis company
2. Froedtert invests $1.5M in local medical imaging startup
3. GE Healthcare invests $37.5 million in Chinese bio-sciences manufacturing facility
4. Wisconsin Insurance Company Invests in DotCom Company
5. Madison business receives $115,000 of new state biofuels funding
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... , ... February 23, 2017 ... ... announced today that in a published evaluation of multiple immunoassay-based threat detection ... Department of Energy Laboratory, PathSensors’ CANARY® biosensor threat detection technology was found ...
(Date:2/23/2017)...  Capricor Therapeutics, Inc. (NASDAQ: CAPR), a biotechnology company developing ... that Linda Marbán, Ph.D, president and chief executive officer, is ... Cowen and Company 37th Annual Health Care Conference ... Boston, MA 29th Annual ROTH ... pm ET) Dana Point, CA ...
(Date:2/22/2017)... Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on ... companion animals, will host a live conference call on Tuesday, ... results from the fourth quarter and full year ended December ... access the audio webcast or use the conference ... ...
(Date:2/22/2017)... 22, 2017 Scientists propose in Nature ... damage in Gaucher and maybe other lysosomal storage diseases ... costs than current therapies. An international research ... , which also included investigators from the University of ... data Feb. 22. The study was conducted in mouse ...
Breaking Biology Technology:
(Date:1/31/2017)... , Jan. 31, 2017  Spero Therapeutics, ... therapies for the treatment of bacterial infections, today ... of antibacterial candidates from Pro Bono Bio Ltd ... prevalence of multi-drug resistant forms of Gram-negative bacteria.  ... Anti Infectives Ltd, a PBB group company. ...
(Date:1/24/2017)... 24, 2017 Biopharm Reports has carried ... use of nuclear magnetic resonance spectroscopy (NMR). This ... profiled current practices, developments, trends and end-user plans ... growth and opportunities. These areas include growth in ... needs and innovation requirements, hyphenated NMR techniques, main ...
(Date:1/19/2017)... CLARA, Calif. , Jan. 19, 2017 /PRNewswire/ ... company enhancing user experience and security for consumer ... of next-generation payment processing systems and cybersecurity solutions, ... more banks, enterprises and financial institutions worldwide to ... part of the end-to-end secure user authentication platforms ...
Breaking Biology News(10 mins):